Program - KSMO Conference

Invited Speaker

Plenary Lecture
Joint Symposium
Scientific Symposium
Multi-Disciplinary Case Discussion
Education Session
Asia Young Oncologist Forum
Luncheon Symposium
Satellite Symposium

Plenary Lecture

Plenary Lecture 1 Breaking new ground: Innovative cancer vaccine therapies

Patrick Ott Dana-Farber Cancer Institute USA CV
Plenary Lecture 2 Cancer cachexia: Transition from science to practice

Jeffrey Crawford Duke Cancer Center USA CV
Plenary Lecture 3 Advances in chemotherapy for gastric cancer- Future perspectives

Kohei Shitara National Cancer Center Hospital East Japan CV
Plenary Lecture 4 Biomarkers to predict efficacy and toxicity of antibody drug conjugates in breast cancer

Giuseppe Curigliano European Institute of Oncology, IRCCS and Università degli Studi di Milano Italy CV

JOINT SYMPOSIUM

Joint Symposium 1 (ASCO/KSMO)

Samuel Klempner Massachusetts General Hospital USA CV
Jeeyun Lee Samsung Medical Center Korea CV
Samuel Cytyrn Memorial Sloan Kettering Cancer Center USA CV
Keun-Wook Lee Seoul National University Bundang Hospital Korea CV

Joint Symposium 2 (KCSG/KSMO) Transforming oncology research: AI-powered clinical trials

Hiromizu Takahashi Juntendo University Urayasu Hospital Japan CV
Kenneth Kehl Dana-Farber Cancer Institute USA CV
Sandip Pravin Patel UC San Diego Moores Cancer Center USA CV
Hannah Kim Yonsei University College of Medicine Korea CV

Joint Symposium 3 (KOSRO /KSMO) Optimization of neoadjuvant/adjuvant treatment

TBD TBD TBD CV
TBD TBD TBD CV
Jang Ho Cho Gachon University Gil Medical Center Korea CV
Jeong Il Yu Samsung Medical Center Korea CV

Joint Symposium 4 (ESMO/KSMO) ESMO guideline and the implementation in Asian Pacific region

TBD TBD TBD CV
TBD TBD TBD CV
TBD TBD TBD CV
Tae Min Kim Seoul National University Hospital Korea CV

Joint Symposium 5 (KSSO/KSMO) Omit surgery in GI cancer treatment

Atsushi Oba Cancer Institute Hospital Japan CV
Minsu Kang Seoul National University Bundang Hospital Korea CV
TBD TBD TBD CV
TBD TBD TBD CV

Joint Symposium 6 (KSR/KSMO)

Young Saing Kim Gachon University Gil Medical Center Korea CV
Min Hwan Kim Yonsei Cancer Center Korea CV
Guillaume Chassagnon Université Paris Cité France CV
Sung Soo Ahn Yonsei University College of Medicine Korea CV

Joint Symposium 7 (JSMO/KSMO) The new standard therapy in solid tumors : The combination of immunotherapies

Junho Lee Kyung Hee University Hospital Korea CV
Hong sik Kim Chungbuk National University Hospital Korea CV
Kenjiro Namikawa National Cancer Center Hospital, Tokyo Japan CV
Kenji Tamura Shimane University Hospital Japan CV

Joint Symposium 8 (KSP/KSMO) Biomarker for ADC

TBD TBD TBD CV
Yoon-La Choi Samsung Medical Center Korea CV
TBD TBD TBD CV
Tae-Yeong Kwak Deep Bio Inc. Korea CV

Joint Symposium 9 (ASCO/KSMO)

Steve Maron Memorial Sloan Kettering Cancer Center USA CV
Sung Hee Lim Samsung Medical Center Korea CV
Haley Ellis Massachusetts General Hospital USA CV
Hyo song Kim Yonsei University College of Medicine Korea CV

Joint Symposium 10 (ESMO/KSMO) How to streamline initiatives for optimising oncology practice

TBD TBD TBD CV
Sang Joon Shin Yonsei Cancer Center Korea CV
TBD TBD TBD CV
TBD TBD TBD CV

SCIENTIFIC SYMPOSIUM

Scientific Symposium 1 Optimizing the transition to palliative care: Prognostic estimation and communication in oncology

TBD TBD TBD CV
TBD TBD TBD CV
Beodeul Kang CHA Bundang Medical Center Korea CV
Eun Mi Nam Ewha Womans University Seoul Hospital Korea CV

Scientific Symposium 2 Revolutionizing GI cancer care with next-generation modalities

TBD TBD TBD CV
TBD TBD TBD CV
TBD TBD TBD CV
TBD TBD TBD CV

Scientific Symposium 3 How shall we treat RARE cancer in the era of precision medicine : Progress and challenges ahead

TBD TBD TBD CV
TBD TBD TBD CV
TBD TBD TBD CV
TBD TBD TBD CV

Scientific Symposium 4 Current trends and future perspectives in GU oncology

TBD TBD TBD CV
TBD TBD TBD CV
Hyeon-Su Im Ulsan University Hospital Korea CV
Hyunho Kim The Catholic University of Korea St. Vincent's Hospital Korea CV

Scientific Symposium 5 Current Insights and future directions of MBC treatment

TBD TBD TBD CV
TBD TBD TBD CV
Kyong Hwa Park Korea University Anam Hospital Korea CV
Gun Min Kim Yonsei University College of Medicine Korea CV

Scientific Symposium 6 Clinical promise of ctDNA-based MRD testing in cancer therapy

TBD TBD TBD CV
TBD TBD TBD CV
Takayuki Yoshino National Cancer Center Hospital East Japan CV
TBD TBD TBD CV

Scientific Symposium 7 Novel opportunities to target cancer: Emerging strategies in molecular oncology

Scott J. Dixon Stanford University USA CV
Erica Sloan Monash University Australia CV
Mi-Young Kim KAIST Korea CV
Hargsoon Yoon Norfolk State University USA CV

Scientific Symposium 8 Combinatory strategy to enhance immune checkpoint response

Changhoon Yoo Asan Medical Center, University of Ulsan College of Medicine Korea CV
TBD TBD TBD CV
Toshio Shimizu Kansai Medical University Hospital, Osaka Japan CV
Kyung Hwan Kim Yonsei Cancer Center Korea CV

Scientific Symposium 9 Real-world challenges in GI oncology: Navigating complex treatment decisions

TBD TBD TBD CV
TBD TBD TBD CV
Choong-kun Lee Yonsei Cancer Center Korea CV
Raghav Sundar Yale School of Medicine USA CV

Scientific Symposium 10 Revealing immune response and resistance through spatial profiling of NSCLC microenvironment

Jaemoon Koh Seoul National University Hospital Korea CV
TBD TBD TBD CV
TBD TBD TBD CV
TBD TBD TBD CV

MULTI-DISCIPLINARY CASE DISCUSSION

Multi-Disciplinary Case Discussion (KOREAN) Personalized treatment strategies for oligometastatic patients in the new era of cancer therapeutics

Chai Hong Rim Korea University College of Medicine Korea CV
In Hee Lee Kyungpook National University Chilgok Hospital Korea CV
Dae-Won Lee Seoul National University College of Medicine Korea CV
Hwa Kyung Byun Yongin Severance Hospital Korea CV

EDUCATION SESSION

Education Session 1 Symptom management in advanced cancer: Innovations and best practices

Hee Jun Kim Chung-Ang University College of Medicine Korea CV
TBD TBD TBD CV
TBD TBD TBD CV
Hee Kyung Ahn Samsung Medical Center Korea CV

Education Session 2 (KOREAN) Tumor heterogeneity and single-cell analysis

Jinhyuk Bhin Yonsei University College of Medicine Korea CV
TBD TBD TBD CV
Hoon Hur Ajou University School of Medicine Korea CV
Yunhak Kim Pusan National University Korea CV

Education Session 3 (KOREAN) Cancer survivorship: Shifting paradigms in care

Yun-Gyoo Lee Kangbuk Samsung Hospital Korea CV
Ji Soo Park Cancer Prevention Center, Yonsei Cancer Center Korea CV
Seockhoon Chung Asan Medical Center Korea CV
Juhee Cho Samsung Comprehensive Cancer Center, Sungkyunkwan University Korea CV

Education Session 4 (KOREAN) Toxicity management in Antibody-Drug Conjugates (ADCs)

In Hae Park Korea University Guro Hospital Korea CV
Han Jo Kim Soonchunhyang University Cheonan Hospital Korea CV
Jimyung Park Seoul National University Hospital Korea CV
Chang Ho Yoon Seoul National University Hospital Korea CV

Education Session 5 (KOREAN) Advance of technology - Artificial intelligence in oncology

Chanyoung Ock Bang & Ock Consulting Inc. Korea CV
Eunkyung Kim Yonsei University College of Medicine Korea CV
Yoon Jin Cha Gangnam Severance Hospital Korea CV
TBD TBD TBD CV

FACO SESSION

FACO Session 1 Recent updates in colorectal cancer treatment

Ying Yuan The Second Affiliated Hospital Zhejiang University School of Medicine China CV
Eiji Oki Kyushu University Japan CV

FACO Session 2 Proposals for new FACO clinical trials

Sehhoon Park Samsung Medical Center Republic of Korea CV
Ning Li Cancer Hospital Chinese Academy of Medical Sciences China CV
Keiichi Fujiwara Saitama Medical University International Medical Center Japan CV

KSMO 2025

전체메뉴